18 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
by a clinical diagnosis of AD confirmed with amyloid biomarkers positron emission tomography, or PET, imaging and/or cerebrospinal fluid, or CSF … biomarkers positron emission tomography, or PET, imaging and/or cerebrospinal fluid, or CSF, biomarkers. Patients will be randomized to receive CT1812
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
with amyloid biomarkers positron emission tomography, or PET, imaging and/or cerebrospinal fluid, or CSF, biomarkers. Participants are being randomized … who have elevated levels of Aβ oligomers as determined by a clinical diagnosis of AD confirmed with amyloid biomarkers positron emission tomography
S-3
CGTX
Cognition Therapeutics Inc
23 Dec 22
Shelf registration
4:16pm
AD who have elevated levels of Aβ oligomers as determined by a clinical diagnosis of AD confirmed with amyloid biomarkers positron emission … emission tomography, or PET, imaging and/or cerebrospinal fluid, or CSF, biomarkers. Patients will be randomized to receive CT1812 or a placebo for 18
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
emission tomography, or PET, imaging and/or cerebrospinal fluid, or CSF, biomarkers. Patients will be randomized to receive CT1812 or a placebo for 18 … emission tomography, or PET, imaging and/or cerebrospinal fluid, or CSF, biomarkers. Patients will be randomized to receive CT1812 or a placebo for 18 months
DRS
213wy5 9f
20 Oct 22
Draft registration statement
12:00am
10-K
b04jsz
30 Mar 22
Annual report
7:40am
424B4
36werv282vmp
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
EX-10.4
w7izfna1bne72
19 Jul 21
IPO registration
7:02am
S-1
9jp9d2 09
19 Jul 21
IPO registration
7:02am
DRS/A
6cqmpxf59c
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
d7z3j5 fvw
7 May 21
Draft registration statement
12:00am
DRS
EX-10.4
a0wlz44
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next